We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Weekly
    • FDAnews
  • Device News
    • Trending
    • Commercial Operations
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Weekly
    • FDAnews
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • FDAnews Editorial Board
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home

RSS Feeds

Clinical Trials Advisor

Clinical Trials Advisor is the one-stop resource for clinical research sponsors and sites investigating novel drugs and medical devices. Turn to CTA for timely information and advice on how to gain new business, improve operations and stay in compliance with the FDA’s GCP requirements. Each biweekly issue offers practical advice on maximizing your clinical investments, updates on the latest regulatory and international news, and more. Plus, it provides links to important documents — such as guidances, warning letters and Form 483s — from the FDA, foreign regulators and global organizations.

Drug GMP Report

For two decades, Drug GMP Report has provided thorough analysis and interpretation of current good manufacturing practice (cGMP) regulations, FDA enforcement trends and warning letters, international regulations and more. It’s like receiving a monthly executive briefing packed with the latest on inspection hot spots, developments in international harmonization efforts, electronic data requirements and evolving trends in cGMP enforcement. Plus, every issue, you get links to critical documents such as draft and final guidances, Form 483s, warning letters, proposed rules, full text of proposed legislation and a host of others.

Drug Industry Daily

This daily electronic briefing delivers coverage of what’s happening on Capitol Hill and at the FDA, FTC, HHS and other key agencies and decision-making bodies that affect the pharmaceutical industry. Each issue gives you hard reporting on top issues, such as patent exclusivity, market globalization, biosimilar development, advertising, program funding, FDA appropriations, warning letters, recalls, approvals and more. Written by FDAnews’ veteran staff of reporters, you get the latest news with the added perspective that only seasoned reporters can provide. It’s the fastest, most reliable way to make sure you’re an industry expert.

International Devices & Diagnostics Letter Monitor

International Devices & Diagnostics Monitor (IDDM) is a one-stop resource that brings you a complete, global picture of the medical device regulations that affect your business. Nowhere else will you find a more comprehensive collection of all the regulatory changes in the US, EU, Asia, Latin America, the Middle East, Australia and the rest of the world. Your subscription includes a weekly newsletter to keep you up to date with global regulations as changes happen, including complete text of all government documents.

Generic Line

For over 25 years, the Generic Line has been the leading resource for accurate, up-to-date analysis of FDA policies affecting generic drugs and drug patents. With a new biosimilars approval path, blockbuster drugs facing patent cliffs, and the FTC trying to stop pay-for-delay agreements, there's never been a more critical time to subscribe. With every issue, you get links to additional key documents, such as FDA guidances, warning letters, rules, full texts of proposed legislation and much more.

International Pharmaceutical Regulatory Monitor

International Pharmaceutical Regulatory Monitor has been a ‘must read’ for pharma professionals for more than 40 years, bringing them the latest changes in rules and standards at the FDA, European Medicines Agency, Health Canada, Australia's TGA, International Conference on Harmonisation and other key organizations. And as the global marketplace has expanded to markets in Latin America, Asia and Africa, IPRM has kept readers informed of regulatory developments in those regions as well. In each issue, you get actual English-language texts of important, hard-to-obtain proposals, regulations, guidances and other documents to help ensure speedy reviews of your regulatory submissions and success at home and abroad.

The GMP Letter

For 30 years, medical device manufacturers worldwide have relied on The GMP Letter to comply with the FDA's interpretation and enforcement of cGMPs and the Quality System Regulation (QSR). In each issue, you get an update on regulations and guidances and learn which companies the FDA has inspected and what the audits revealed. You also get links to Form 483s, warning letters, closeout letters, FDA policy notices and many other reports to help make your quality assurance efforts a success.

FDAnews Device Daily Bulletin

Each day you'll receive targeted FDA regulatory, legislative and business news briefs in the pharmaceutical and biologics industries. Plus, you'll get a snapshot of international news relevant to your business. In just a few minutes you can scan major headlines and click through to read the stories you want. Sign up today and receive your first FDAnews Drug Daily Bulletin the next business day. This subscription includes a weekly email alert, FDAnews' Pharma Solution of the Week, highlighting one problem and one solution in the pharmaceutical arena.

FDAnews Drug Daily Bulletin

Each day you'll receive targeted FDA regulatory, legislative and business news briefs in the pharmaceutical and biologics industries. Plus, you'll get a snapshot of international news relevant to your business. In just a few minutes you can scan major headlines and click through to read the stories you want. Sign up today and receive your first FDAnews Drug Daily Bulletin the next business day. This subscription includes a weekly email alert, FDAnews' Pharma Solution of the Week, highlighting one problem and one solution in the pharmaceutical arena.

QMN Weekly Bulletin

By reading the Quality Management Network's QMN Weekly Bulletin you can keep track of the latest from the FDA, Congress and industry experts in the world of cGMP's for pharmaceutical and medical device manufacturers. Each issue delivers crucial information on regulatory changes and inspection trends, as well as a wrap-up of the major quality management news from around the world. Sign up today and start receiving The QMN Weekly Bulletin.

Topic Feeds

Commercial Operations

GMPs

Inspections and Audits

Postmarket Safety

Quality

Regulatory Affairs

Research and Development

Submissions and Approvals

Commercial Operations

Inspections and Audits

Postmarket Safety

Quality

Regulatory Affairs

Research and Development

Submissions and Approvals

QSR

FDA Enforcement Actions

Legislative Update

Meeting Planner

Quick Notes

Regulatory Update

COVID-19

Upcoming Events

  • 28Sep

    The Cost of Counterfeiting: Why You Need a Plan to Secure Your Medical Device Supply Chain

  • 28Sep

    Calculating Sample Size to Satisfy FDA Expectations

  • 11Oct

    GMP Quality Management vSummit 2023: Where Quality Meets Risk

  • 16Oct

    MAGI@home Clinical Research Conference 2023

  • 26Oct

    FDA in 2024: What to Expect in an Election Year

  • 08Nov

    18th Annual FDA Inspections vSummit

Featured Products

  • FDA, FTC and DOJ Enforcement of Medical Device Regulations

    FDA, FTC and DOJ Enforcement of Medical Device Regulations

  • Using Real-World Evidence in Drug and Device Submissions

    Using Real-World Evidence in Drug and Device Submissions

Featured Stories

  • Top Concern for CBER is Marketing of Unapproved Biologics, Says FDA Official

  • FDA Deems Medline Industries’ Saline Solution Vial Recall as Class 1

  • FDA Adcomm Votes Down Intarcia’s T2 Diabetes Combo Product

  • Mixed Reality Neurosurgery Navigation and CAD Detection Systems Gets FDA Clearance

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing